Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Benign Prostatic Hyperplasia
91%
Prostatic Artery Embolization
73%
Prostate Cancer
71%
Cribriform
37%
Prostate-specific Antigen
36%
Urine Proteome
32%
Intraductal Carcinoma of the Prostate
30%
Bladder Cancer
29%
Lower Urinary Tract Symptoms
28%
Prostate Volume
28%
Prostate Health Index
27%
Cribriform Pattern
27%
Protein Signature
27%
Proteome
26%
International Prostate Symptom Score
26%
Prostatic Arterial Embolization
25%
Embolization
22%
Prostate Carcinoma
20%
Urinary Extracellular Vesicles
20%
Prostate Cancer Screening
20%
Proteomic Analysis
20%
Negative Biopsy
18%
ProPSA
18%
Total Prostate-specific Antigen
18%
Absolute Protein Quantification
18%
Free PSA
18%
Tertiary Hospital
18%
T1 Bladder Cancer
18%
Urological Cancer
18%
Muscle-invasive
18%
Vesicle Protein
18%
Total Protein Approach
18%
Non-muscle Invasive Bladder Cancer (NMIBC)
18%
Adverse Outcomes
18%
Intraductal
18%
Intraductal Carcinoma
18%
Prostate
17%
Cm(III)
16%
Beckman Coulter
16%
Clinically Significant
15%
Extracellular Vesicle Proteome
15%
Active Surveillance
14%
Quality of Life
14%
Non-spherical
13%
Prostatic Artery
13%
Prostate Biopsy
13%
Clinical Outcomes
13%
Urology
13%
Cancer Patients
13%
Medical Treatment
12%
Medicine and Dentistry
Arterial Embolization
100%
Prostate Cancer
93%
Prostate Hypertrophy
92%
Prostate Specific Antigen
46%
Biopsy Technique
40%
Urinary System
40%
Bladder Cancer
31%
Recurrent Disease
31%
Proteome
31%
International Prostate Symptom Score
26%
Quality of Life
24%
Lower Urinary Tract Symptom
23%
Embolization
23%
Urology
22%
Diseases
22%
Proteomics
21%
Prostate Carcinoma
18%
Adverse Outcome
18%
Cross Sectional Study
18%
Combination Therapy
17%
Pelvis
15%
Malignant Neoplasm
15%
Retrospective Study
14%
Invasive Procedure
13%
Magnetic Resonance Imaging
13%
Polyvinyl Alcohol
13%
Bladder
13%
Prostatectomy
13%
Cancer
13%
Intraductal Carcinoma
12%
Diagnostic Performance
11%
Patient Referral
11%
Multiparametric Magnetic Resonance Imaging
11%
Residual Volume
10%
Biochemical Recurrence
10%
Cubilin
10%
Myeloperoxidase
10%
Biological Marker
10%
Clinical Decision Making
9%
Polyneuropathy
9%
Personalized Medicine
9%
Amyloid Neuropathy
9%
Disease Course
9%
Open Surgery
9%
Monotherapy
9%
Primary Tumor
9%
Exclusion Criterion
9%
Arterial Circulation
9%
Sham Procedure
9%
COVID-19
9%